Collamati, Francesco
van Oosterom, Matthias N.
De Simoni, Micol
Faccini, Riccardo http://orcid.org/0000-0003-2613-5141
Fischetti, Marta
Mancini Terracciano, Carlo
Mirabelli, Riccardo
Moretti, Roberto
Heuvel, Judith olde
Solfaroli Camillocci, Elena
van Beurden, Florian
van der Poel, Henk G.
Valdes Olmos, Renato A.
van Leeuwen, Pim J.
van Leeuwen, Fijs W. B.
Morganti, Silvio
Funding for this research was provided by:
Sapienza Università di Roma (RM116154C8EF4FBC)
Article History
Received: 23 June 2020
Accepted: 28 July 2020
First Online: 6 August 2020
Ethics approval and consent to participate
: The study was approved by the local ethics committee (NL66218.031.18) and all patients provided a written informed consent.
: Not applicable
: F.C. and R.F are listed as inventors on an Italian patent application (RM2013A000053) entitled “Utilizzo di radiazione beta- per la identificazione intraoperatoria di residui tumorali e la corrispondente sonda di rivelazione” dealing with the implementation of an intraoperative beta- probe for radioguided surgery according to the results presented in this paper. The same authors are also inventors in the PCT patent application (PCT/IT2014/000025) entitled “Intraoperative detection of tumor residues using beta- radiation and corresponding probes” covering the method and the instruments described in this paper.FWB van Leeuwen is a consultant for Hamamatsu Photonics and is Chief Innovation Officer at ORSI Academy.No other potential conflicts of interest relevant to this article exist.